Inside STAT: Experts call for more research on pregnant and lactating women
There’s very little research on whether medications are safe and effective in pregnant and lactating women, but a task force formed by Congress has ideas to close that information gap — and just fired off 15 recommendations to health officials. Among them:
- Liability: A huge hurdle to inclusion is fear about liability if a medication harms a pregnant woman or her fetus. The task force says the government needs to come up with a system to cover liability for study sponsors.
- Education: The task force says HHS should create an educational campaign that get both the public and health care providers talking about the importance of research on pregnant and lactating women.
- Incentives: Give drug companies an incentive to study drugs in pregnant and lactating women, like longer patent exclusivity if they carry out studies in those populations.
No hay comentarios:
Publicar un comentario